Cyberkinetics Neurotechnology Systems, Inc. Receives Notification Of Key Patent Allowance For Treatment Of Spinal Cord Injury Using The Andara(TM) OFS(TM) PLUS Device

FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; Cyberkinetics), a neurotechnology company focused on neurostimulation and neural sensing to restore function, announced that a notification of allowance has been received from the U.S. Patent and Trademark Office for publication number US20040214790A1, entitled “Method of Treatment for Spinal Cord Injury”. The patent relates to the Company’s Andara™ Oscillating Field Stimulator (OFS™) neural stimulation technology platform.
MORE ON THIS TOPIC